Synaptogenix, Inc. (NASDAQ:SNPX) Short Interest Up 183.2% in April

Synaptogenix, Inc. (NASDAQ:SNPX) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 33,700 shares, an increase of 183.2% from the March 31st total of 11,900 shares. Based on an average daily volume of 48,500 shares, the days-to-cover ratio is presently 0.7 days. Currently, 3.2% of the shares of the company are short sold.

Synaptogenix Stock Up 2.7 %

NASDAQ SNPX traded up $0.12 on Friday, hitting $4.53. The stock had a trading volume of 6,926 shares, compared to its average volume of 74,924. The company’s 50-day moving average is $4.79 and its two-hundred day moving average is $5.85. Synaptogenix has a one year low of $3.53 and a one year high of $47.00. The stock has a market cap of $4.92 million, a price-to-earnings ratio of -0.17 and a beta of 1.33.

About Synaptogenix

Synaptogenix, Inc operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease.